Subscribe

Nephrogenic Systemic Fibrosis Associated with Use of Gadolinium-Based Contrast Agents

Purpose:

To evaluate a patient for nephrogenic systemic fibrosis (NSF) following use of a gadolinium-based contrast agent (GBCA) during an MRI.

Specialty:

Hematology Oncology
Clinical Pharmacology & Toxicology

Objective:

response to therapy, adverse effects, complication detection

ICD-10:

N00-N99

Description:

Use of gadolinium-based contrast agents (GBCA) in a patient with renal disease may be followed by development of nephrogenic systemic fibrosis (NSF, nephrogenic fibrosing dermatopathy).

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone